Movement Alert｜JD Health Rises 3.68% in Regular Trading, Partners with Everest Medicines to Build Innovative Drug Full-Cycle Service Platform

Market Focus07-16 09:49

On July 16, JD Health rose 3.68% in regular trading, trading at HKD 38.5 per share, with turnover of HKD 55.48 million. The gain was driven by the announcement of a strategic partnership with biopharmaceutical company Everest Medicines.

On July 15, JD Health and Everest Medicines signed a strategic cooperation agreement. The two parties will collaborate on innovative drug new product launches, patient services, digital marketing, and internet healthcare. Under the agreement, Everest Medicines will prioritize launching new products on the JD Health platform, leveraging first-tier direct supply, omni-channel supply chain coordination, and digital academic marketing to improve drug accessibility and service quality. Everest Medicines' oral innovative drugs, including Nefecon and Filsuvez, are already available on the JD Health platform.

Within the Internet and Direct Marketing Retail sector, the broader sector showed strength. Among individual stocks, BABA-W up 3.79%, MEITUAN-W up 3.78%, ALI HEALTH up 2.98%, PA GOODDOCTOR up 2.82%, JD-SW up 2.16%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1107739965?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-16 09:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1107739965","market":"us","top_or_hot":-1,"title":"Movement Alert｜JD Health Rises 3.68% in Regular Trading, Partners with Everest Medicines to Build Innovative Drug Full-Cycle Service Platform","media":"Market Focus","content":"<p><p>On July 16, JD Health rose 3.68% in regular trading, trading at HKD 38.5 per share, with turnover of HKD 55.48 million. The gain was driven by the announcement of a strategic partnership with biopharmaceutical company Everest Medicines.</p><p>On July 15, JD Health and Everest Medicines signed a strategic cooperation agreement. The two parties will collaborate on innovative drug new product launches, patient services, digital marketing, and internet healthcare. Under the agreement, Everest Medicines will prioritize launching new products on the JD Health platform, leveraging first-tier direct supply, omni-channel supply chain coordination, and digital academic marketing to improve drug accessibility and service quality. Everest Medicines' oral innovative drugs, including Nefecon and Filsuvez, are already available on the JD Health platform.</p><p>Within the Internet and Direct Marketing Retail sector, the broader sector showed strength. Among individual stocks, BABA-W up 3.79%, MEITUAN-W up 3.78%, ALI HEALTH up 2.98%, PA GOODDOCTOR up 2.82%, JD-SW up 2.16%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜JD Health Rises 3.68% in Regular Trading, Partners with Everest Medicines to Build Innovative Drug Full-Cycle Service Platform</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜JD Health Rises 3.68% in Regular Trading, Partners with Everest Medicines to Build Innovative Drug Full-Cycle Service Platform\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-16 09:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 16, JD Health rose 3.68% in regular trading, trading at HKD 38.5 per share, with turnover of HKD 55.48 million. The gain was driven by the announcement of a strategic partnership with biopharmaceutical company Everest Medicines.</p><p>On July 15, JD Health and Everest Medicines signed a strategic cooperation agreement. The two parties will collaborate on innovative drug new product launches, patient services, digital marketing, and internet healthcare. Under the agreement, Everest Medicines will prioritize launching new products on the JD Health platform, leveraging first-tier direct supply, omni-channel supply chain coordination, and digital academic marketing to improve drug accessibility and service quality. Everest Medicines' oral innovative drugs, including Nefecon and Filsuvez, are already available on the JD Health platform.</p><p>Within the Internet and Direct Marketing Retail sector, the broader sector showed strength. Among individual stocks, BABA-W up 3.79%, MEITUAN-W up 3.78%, ALI HEALTH up 2.98%, PA GOODDOCTOR up 2.82%, JD-SW up 2.16%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京东健康","start_time":0,"source_url":"","article_id":"1107739965","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1107739965","pubTimestamp":1784166578,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 16, JD Health rose 3.68% in regular trading, trading at HKD 38.5 per share, with turnover of HKD 55.48 million. The gain was driven by the announcement of a strategic partnership with...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"异动提醒|京东健康常规交易涨3.68%，携手珠峰医药共建创新药全周期服务平台","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"On July 16, JD Health rose 3.68% in regular trading, trading at HKD 38.5 per share, with turnover of HKD 55.48 million. The gain was driven by the announcement of a strategic partnership with biopharmaceutical company Everest Medicines.On July 15, JD Health and Everest Medicines signed a strategic cooperation agreement. The two parties will collaborate on innovative drug new product launches, patient services, digital marketing, and internet healthcare. Under the agreement, Everest Medicines will prioritize launching new products on the JD Health platform, leveraging first-tier direct supply, omni-channel supply chain coordination, and digital academic marketing to improve drug accessibility and service quality. Everest Medicines' oral innovative drugs, including Nefecon and Filsuvez, are already available on the JD Health platform.Within the Internet and Direct Marketing Retail sector, the broader sector showed strength. Among individual stocks, BABA-W up 3.79%, MEITUAN-W up 3.78%, ALI HEALTH up 2.98%, PA GOODDOCTOR up 2.82%, JD-SW up 2.16%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1107739965","isCrawlerRequest":true}